Back to search

Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics

Data up to Jan 2025

Published2001
Citations590
References134

Total Citations Per Year

Abstract

References (134)

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1997 • 9,861 citations

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1976 • 3,228 citations

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

1987 • 2,788 citations

A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases

1998 • 2,483 citations

Active Transport of Sodium as the Source of Electric Current in the Short‐circuited Isolated Frog Skin.

1951 • 2,379 citations

A physiological approach to hepatic drug clearance

1975 • 1,855 citations

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

1991 • 1,787 citations

Prediction of Physicochemical Parameters by Atomic Contributions

1999 • 1,246 citations

Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes

1998 • 1,205 citations

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1995 • 1,109 citations

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms.

1998 • 1,060 citations

MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening

1999 • 895 citations

Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs.

1999 • 757 citations

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*

1996 • 598 citations

Property distribution of drug-related chemical databases.

2000 • 594 citations

Molecular fields in quantitative structure–permeation relationships: the VolSurf approach

2000 • 550 citations

A general pattern for substrate recognition by P‐glycoprotein

1998 • 530 citations

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.

1994 • 526 citations

Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists

1988 • 514 citations

Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?

1998 • 470 citations

Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).

1988 • 467 citations

Estimating skin permeation. The validation of five mathematical skin permeation models

1995 • 460 citations

Correlation of Human Jejunal Permeability (in Vivo) of Drugs with Experimentally and Theoretically Derived Parameters. A Multivariate Data Analysis Approach

1998 • 436 citations

Role of P-Glycoprotein and Cytochrome P450 3A in Limiting Oral Absorption of Peptides and Peptidomimetics†

1998 • 418 citations

Predicting Blood−Brain Barrier Permeation from Three-Dimensional Molecular Structure

2000 • 418 citations

pH-metric logP 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs.

1998 • 401 citations

Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*

1997 • 396 citations

Lipophilicity in Drug Action and Toxicology

1996 • 396 citations

A Scoring Scheme for Discriminating between Drugs and Nondrugs

1998 • 386 citations

Pharmacokinetics and pharmacodynamics of the monoamine oxidase B inhibitor mofegiline assessed during a phase I dose tolerance trial

1995 • 381 citations

Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion

1998 • 357 citations

Intestinal absorption of peptides

1975 • 353 citations

A High-Throughput Screening Method for the Determination of Aqueous Drug Solubility Using Laser Nephelometry in Microtiter Plates

2000 • 333 citations

Active secretion and enterocytic drug metabolism barriers to drug absorption

1996 • 310 citations

Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments.

1993 • 306 citations

Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction

1997 • 299 citations

Designing Libraries with CNS Activity

1999 • 293 citations

A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity.

1995 • 287 citations

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

1997 • 283 citations

First-pass metabolism of midazolam by the human intestine*

1996 • 281 citations

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

1996 • 280 citations

Structure–activity relationship of P-glycoprotein substrates and modifiers

2000 • 277 citations

Caco-2 monolayers in experimental and theoretical predictions of drug transport

1996 • 268 citations

Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics

1996 • 226 citations

The influence of peptide structure on transport across Caco-2 cells.

1991 • 223 citations

The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.

1986 • 222 citations

Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation

1996 • 221 citations

pH-Metric log P. II: Refinement of Partition Coefficients and Ionization Constants of Multiprotic Substances

1993 • 220 citations

Soft drug design: General principles and recent applications

2000 • 215 citations

Pharmacokinetic Optimization in Drug Research

2001 • 213 citations

Untitled

2000 • 210 citations

Evaluation of Dynamic Polar Molecular Surface Area as Predictor of Drug Absorption: Comparison with Other Computational and Experimental Predictors

1998 • 206 citations

Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption.

1999 • 200 citations

Computation of Brain−Blood Partitioning of Organic Solutes via Free Energy Calculations

1996 • 199 citations

Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans.

1995 • 190 citations

QSAR: Rational approaches to the design of bioactive compounds

1991 • 185 citations

A textbook of drug design and development

1991 • 184 citations

Transport of celiprolol across human intestinal epithelial (Caco‐2) cells: mediation of secretion by multiple transporters including P‐glycoprotein

1993 • 178 citations

Octanol-Water Partition: Searching for Predictive Models

1998 • 169 citations

Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans.

1997 • 169 citations

Review of theoretical passive drug absorption models: Historical background, recent developments and limitations

1996 • 167 citations

Pharmacokinetics and metabolism in early drug discovery

1999 • 160 citations

On the Partition of Ampholytes: Application to Blood–Brain Distribution

1997 • 139 citations

The Functional Role of P-Glycoprotein in the Blood–Brain Barrier

1997 • 138 citations

Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship.

2000 • 136 citations

Permeability of Red Cell Membranes to Small Hydrophilic and Lipophilic Solutes

1971 • 134 citations

THE PHARMACOLOGICAL ROLE OF P-GLYCOPROTEIN IN THE INTESTINAL EPITHELIUM

1998 • 130 citations

Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features

2000 • 129 citations

Chemoinformatics – predicting the physicochemical properties of 'drug-like' molecules

2000 • 129 citations

Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein††Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday.

1999 • 129 citations

Theoretical Calculation and Prediction of Brain–Blood Partitioning of Organic Solutes Using MolSurf Parametrization and PLS Statistics

1998 • 124 citations

Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier.

1998 • 116 citations

Felodipine kinetics in healthy men

1985 • 114 citations

Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo.

1996 • 112 citations

Polar intermolecular interactions encoded in partition coefficients: an indirect estimation of hydrogen-bond parameters of polyfunctional solutes

1992 • 109 citations

Nifedipine: Kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration

1986 • 103 citations

Epidermal permeability–penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge

2000 • 97 citations

In Vivo Pharmacokinetics of Felodipine Predicted from in Vitro Studies in Rat, Dog and Man

1986 • 95 citations

Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics

1999 • 92 citations

Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions

1997 • 91 citations

Medicinal chemistry : principles and practice

1994 • 91 citations

Chemoinformatics — a new name for an old problem?

1999 • 88 citations

Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.

1996 • 86 citations

Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium

1998 • 83 citations

Structure–activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements

1999 • 77 citations

Combining in Vitro and in Vivo Pharmacokinetic Data for Prediction of Hepatic Drug Clearance in Humans by Artificial Neural Networks and Multivariate Statistical Techniques

1999 • 76 citations

Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics

2000 • 75 citations

Untitled

2000 • 74 citations

Use of immobilized artificial membrane chromatography for drug transport applications††Abbreviations: blood-brain barrier, BBB; bovine brain microvessel endothelial cells, BBMEC; calculated log distribution coefficient (Pallas, CompuDrug, Budapest, Hungary), ClogD; calculated log partition coefficient, ClogP; capacity factor on an IAM column, k¢IAM; capacity factor on a reversed-phase column, k¢w; log distribution coefficient, log D; immobilized artificial membrane, IAM; nonsteroidal …

1998 • 74 citations

Congeneric Behavior in Estimations of Octanol−Water Partition Coefficients by Micellar Electrokinetic Chromatography

2000 • 73 citations

Quantitative estimation of hydrogen bond contribution to permeability and absorption processes of some chemicals and drugs

1998 • 72 citations

Determination of liposome partitioning of ionizable drugs by titration

1999 • 71 citations

Lipophilicity Behavior of Model and Medicinal Compounds containing a suilfide, sulfoxide, or sulfone moiety

1997 • 70 citations

Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats.

1998 • 69 citations

Interspecies scaling: A comparative study for the prediction of clearance and volume using two or more than two species

1996 • 69 citations

Benzazepinone calcium channel blockers. 2. Structure activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones

1992 • 68 citations

Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects

1999 • 67 citations

Synthesis of a series of compounds related to betaxolol, a new .beta.1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases

1987 • 66 citations

Disposition and bioavailability of the β1‐adrenoceptor antagonist talinolol in man

1995 • 62 citations

Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects.

1991 • 61 citations

Comparison of passive drug transport through Caco-2 cells and artificial membranes

1997 • 60 citations

Hydrogen Bonding Parameters for QSAR: Comparison of Indicator Variables, Hydrogen Bond Counts, Molecular Orbital and Other Parameters

1998 • 59 citations

Pharmacodynamics of variable patient compliance: implications for pharmaceutical value

1998 • 56 citations

A comparative in vitro study of percutaneous penetration of β-blockers in human skin

2000 • 55 citations

Drug Absorption II: Effect of Fasting on Intestinal Drug Absorption

1969 • 55 citations

Metabolism and structure activity data based drug design: discovery of (−) SCH 53079 an analog of the potent cholesterol absorption inhibitor (−) SCH 48461

1996 • 54 citations

Pharmacokinetics of felodipine in patients with liver disease

1989 • 53 citations

Unified Model for the Corneal Permeability of Related and Diverse Compounds with Respect to Their Physicochemical Properties

1996 • 53 citations

An Assessment of the Reaction Energetics for Cytochrome P450-Mediated Reactions

2001 • 50 citations

Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo:

2000 • 48 citations

Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro

1994 • 48 citations

New Targets for Antimalarial Drug Discovery

1997 • 45 citations

Spectrophotometric determination of pKa values based on a pH gradient flow-injection system

2000 • 44 citations

Renin inhibitors containing .psi.[CH2O] pseudopeptide inserts

1988 • 37 citations

Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.

1996 • 35 citations

Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability.

1997 • 34 citations

Permeability of 5-fluorouracil and prodrugs in Caco-2 cell monolayers

1996 • 31 citations

Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression

2000 • 31 citations

The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671

2000 • 31 citations

In vitro models of the blood–brain barrier to polar permeants: Comparison of transmonolayer flux measurements and cell uptake kinetics using cultured cerebral capillary endothelial cells

1999 • 30 citations

Pharmacokinetics of xamoterol after intravenous and oral administration to volunteers

1988 • 22 citations

Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: THE ALLOMETRIC APPROACH FOR INTERSPECIES SCALING OF PHARMACOKINETICS AND TOXICITY OF ANTI‐CANCER DRUGS

1995 • 20 citations

Insight into the lipophilicity of the aromatic N-oxide moiety.

1996 • 19 citations

Pharmacokinetic studies with atenolol in the dog

1983 • 18 citations

Untitled

2000 • 18 citations

Pharmacokinetics and metabolism of zamifenacin in mouse, rat, dog and man

1996 • 18 citations

Intrinsic and Intramolecular Lipophilicity Effects in O‐Glucuronides

1998 • 17 citations

Pharmacokinetics and metabolism of a sulphamide NK2antagonist in rat, dog and human

2000 • 15 citations

Conformationally defined adrenergic agents. 5. Resolution, absolute configuration, and pharmacological characterization of the enantiomers of 2-(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthyl)imidazoline: a potent agonist at .alpha.-adrenoceptors

1987 • 15 citations

Rapid Scanning Technique for the Determination of Optimal Tandem Mass Spectrometric Conditions for Quantitative Analysis

1997 • 14 citations

In vivo non-linear intestinal permeability of celiprolol and propranolol in conscious dogs: evidence for intestinal secretion

1998 • 13 citations

The influence of lipophilicity upon the nasal absorption of a series of hexapeptides

1996 • 6 citations

Regulation of the physical and biochemical composition of blood and seminal plasma by the blood-testis barrier in Labeo ruddi and Labeo rosae (Pisces: Cyprinidae)

1992 • 5 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics (2001) – Journal of Medicinal Chemistry | Metascience Observatory Explorer